Back to trial details

Intake questionnaire

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Applying to Fairfield Medical Center · Lancaster, Ohio

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Anatomic Stage II Breast Cancer AJCC v8?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Lancaster for study visits?